These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11831837)

  • 1. The MRC/BHF Heart Protection Study: preliminary results.
    Collins R; Peto R; Armitage J
    Int J Clin Pract; 2002; 56(1):53-6. PubMed ID: 11831837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
    Collins R; Armitage J; Parish S; Sleight P; Peto R;
    Lancet; 2004 Mar; 363(9411):757-67. PubMed ID: 15016485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
    Collins R; Armitage J; Parish S; Sleigh P; Peto R;
    Lancet; 2003 Jun; 361(9374):2005-16. PubMed ID: 12814710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience.
    Eur Heart J; 1999 May; 20(10):725-41. PubMed ID: 10329064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.
    Heart Protection Study Collaborative Group
    Lancet; 2002 Jul; 360(9326):23-33. PubMed ID: 12114037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
    Heart Protection Study Collaborative Group
    Lancet; 2002 Jul; 360(9326):7-22. PubMed ID: 12114036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
    Brown BG; Zhao XQ; Chait A; Fisher LD; Cheung MC; Morse JS; Dowdy AA; Marino EK; Bolson EL; Alaupovic P; Frohlich J; Albers JJ
    N Engl J Med; 2001 Nov; 345(22):1583-92. PubMed ID: 11757504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).
    Strandberg TE; Pyörälä K; Cook TJ; Wilhelmsen L; Faergeman O; Thorgeirsson G; Pedersen TR; Kjekshus J;
    Lancet; 2004 Aug 28-Sep 3; 364(9436):771-7. PubMed ID: 15337403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients.
    Averna M; Zaninelli A; Le Grazie C; Gensini GF
    J Clin Lipidol; 2010; 4(4):272-8. PubMed ID: 21122660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics.
    Stone PH; Lloyd-Jones DM; Johnstone M; Carlson W; Rubenstein J; Creager M; Frei B; Sopko G; Clark ME; Maccallum G; Kinlay S; Orav J; Selwyn AP
    Am Heart J; 2004 May; 147(5):875-82. PubMed ID: 15131545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study.
    Cook NR; Albert CM; Gaziano JM; Zaharris E; MacFadyen J; Danielson E; Buring JE; Manson JE
    Arch Intern Med; 2007 Aug 13-27; 167(15):1610-8. PubMed ID: 17698683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
    Polis AB; Abate N; Catapano AL; Ballantyne CM; Davidson MH; Smugar SS; Tershakovec AM
    Metab Syndr Relat Disord; 2009 Dec; 7(6):601-10. PubMed ID: 19929597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study).
    Garmendia F; Brown AS; Reiber I; Adams PC
    Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393].
    Heart Protection Study Collaborative Group
    BMC Med; 2005 Mar; 3():6. PubMed ID: 15771782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study.
    Pedersen TR; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Holme I; Larsen ML; Bendiksen FS; Lindahl C; Palmer G;
    Am J Cardiol; 2004 Sep; 94(6):720-4. PubMed ID: 15374773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.
    McCormack T; Harvey P; Gaunt R; Allgar V; Chipperfield R; Robinson P;
    Int J Clin Pract; 2010 Jul; 64(8):1052-61. PubMed ID: 20487050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding indications of statins; implications of the Heart Protection Study.
    Salam AM
    Expert Opin Investig Drugs; 2003 Mar; 12(3):509-13. PubMed ID: 12605572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant vitamins and the prevention of coronary heart disease.
    Adams AK; Wermuth EO; McBride PE
    Am Fam Physician; 1999 Sep; 60(3):895-904. PubMed ID: 10498115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.